Effects of Intermittent Fasting During Ramadan on Insulin-like Growth Factor-1, Interleukin 2, and Lipid Profile in Healthy Muslims
Overview
Affiliations
Background: Insulin-like growth factor-1 (IGF-1) and interleukin-2 (IL-2) play an essential role in pathophysiology of several chronic diseases. As a stressor, fasting in Ramadan may increase inflammatory markers such as IGF-1 and IL-2 in Muslims. The aim of this before-after study was to investigate the effects of fasting in Ramadan on IGF-1 and IL-2 levels in individuals.
Methods: In all, 34 men age 16-64 years were selected out of the overall number of individuals who were ready for fasting entirely throughout Ramadan. A sample of blood was drawn from the contributors before and after Ramadan, and plasma IGF-1, IL-2, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were determined. To identify differences between the initial and final values of test results of the study for plasma IGF-1, IL-2, and lipid parameters, we used paired sample -test.
Results: Paired sample -test illustrated a significant decrease in IGF-1 and IL-2 levels after Ramadan fasting compared to before Ramadan. The concentration of TG, cholesterol, and LDL-C levels underwent significant decreases over the period of the study. HDL-C levels did not change significantly during the study. A significant decrease in weight, waist circumferences, calorie, carbohydrate, and fat intake were observed in participants during Ramadan fasting.
Conclusions: It is concluded that fasting in Ramadan independent of anthropometric measures attenuates inflammation and is beneficiary to health.
Dietary Restrictions and Cancer Prevention: State of the Art.
Caprara G, Pallavi R, Sanyal S, Pelicci P Nutrients. 2025; 17(3).
PMID: 39940361 PMC: 11820753. DOI: 10.3390/nu17030503.
AlKurd R, Mahrous L, Zeb F, Khan M, Alhaj H, Khraiwesh H Medicina (Kaunas). 2024; 60(1).
PMID: 38276070 PMC: 10819730. DOI: 10.3390/medicina60010191.
Intermittent Fasting and Reduction of Inflammatory Response in a Patient with Ulcerative Colitis.
Roco-Videla A, Villota-Arcos C, Pino-Astorga C, Mendoza-Puga D, Bittner-Ortega M, Corbeaux-Ascui T Medicina (Kaunas). 2023; 59(8).
PMID: 37629743 PMC: 10456230. DOI: 10.3390/medicina59081453.
Ezzati A, Rosenkranz S, Horne B Nutrients. 2022; 14(20).
PMID: 36296982 PMC: 9607422. DOI: 10.3390/nu14204299.
Bhatti S, Mindikoglu A Metabol Open. 2022; 13:100162.
PMID: 34977523 PMC: 8713419. DOI: 10.1016/j.metop.2021.100162.